Jenny Ostendorp

MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I

Johannes Brägelmann, Carina Lorenz, Sven Borchmann et al. · Nature Communications · 2021 · 76 citations · Full text

Medicine, Cancer Biology, Oncology +17

Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine

Theresa D. Ahrens, Sylvia Timme, Jens Hoeppner et al. · Epigenetics · 2015 · 75 citations · Full text

Medicine, Oncology, Pharmacology +17

Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations

Jonas S. Jutzi, Titiksha Basu, Maximilian Pellmann et al. · Blood · 2019 · 38 citations · Full text

Medicine, Molecular Genetics, Oncology +12

Response of esophageal cancer cells to epigenetic inhibitors is mediated via altered thioredoxin activity

Theresa D. Ahrens, Sylvia Timme, Jenny Ostendorp et al. · Laboratory Investigation · 2015 · 15 citations · Full text

Medicine, Molecular Biology, Oncology +16

Characterizing Evolutionary Dynamics Reveals Strategies to Exhaust the Spectrum of Subclonal Resistance in EGFR-Mutant Lung Cancer

Nina Müller, Carina Lorenz, Jenny Ostendorp et al. · Cancer Research · 2023 · 14 citations

Medicine, Molecular Biology, Oncology +17